UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000015516
Receipt No. R000017916
Scientific Title Randomized, optimal dose finding, Phase II Study of triweekly Abraxane in patients with metastatic breast cancer.
Date of disclosure of the study information 2014/11/01
Last modified on 2019/07/17 10:33:57

No. Disposal Last modified on Item of update
1 Insert 2014/10/24 09:48:27
2 Update 2015/01/05 15:45:01 Organization
Organization
Category of Funding Organization
Name of secondary funder(s)
Name of secondary funder(s)
3 Update 2015/04/27 16:45:20 Email
4 Update 2015/05/01 17:14:01 Recruitment status
Anticipated trial start date
Last follow-up date
5 Update 2015/05/07 10:03:38 Email
6 Update 2016/06/10 13:18:18 Address
Address
Address
Address
Name of primary sponsor
Organization
7 Update 2016/10/25 09:15:02 Last name of contact person
Last name of contact person
8 Update 2016/12/08 12:12:09 Recruitment status
9 Update 2018/11/01 15:54:09 Last name of contact person
Last name of contact person
10 Update 2018/11/01 15:57:19 Last name of contact person
Last name of contact person
11 Update 2019/06/16 01:47:35 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email1
Organization
Organization
Address
Address
Tel
Email
12 Update 2019/07/17 10:32:21 UMIN ID1
13 Update 2019/07/17 10:33:57 Recruitment status
Date of IRB


Contact us.